Savara (SVRA) EPS (Basic) (2010 - 2026)

Savara (SVRA) posted quarterly EPS (Basic) of -$0.15 for Q1 2026, down 19.44% year-over-year from -$0.18 in Q1 2025, and down 1.55% quarter-over-quarter from -$0.14 in Q4 2025.

Savara (SVRA) EPS (Basic) (2010 - 2026) Analysis & Trends

Savara (SVRA) has reported EPS (Basic) for 17 consecutive years, with -$0.15 the latest figure, recorded in Q1 2026.

  • In Q1 2026, EPS (Basic) fell 19.44% year-over-year to -$0.15; the TTM figure through Mar 2026 stood at -$0.51 (down 8.15% YoY), while the FY2025 annual figure was -$0.53, down 10.46% from the prior year.
  • EPS (Basic) declined to -$0.15 in Q1 2026 per SVRA's latest filing, from -$0.14 in the prior quarter.
  • Across five years, EPS (Basic) topped out at -$0.05 in Q1 2022 and bottomed at -$0.15 in Q1 2026.
  • Historically, EPS (Basic) has averaged -$0.1 across 5 years, with a median of -$0.11 in 2024.
  • Annual changes were most pronounced in 2022 — EPS (Basic) surged 59.06% — and 2024, when it slumped 62.67%.
  • Savara's EPS (Basic) stood at -$0.07 in 2022, then slumped by 44.54% to -$0.1 in 2023, then sank by 50.38% to -$0.15 in 2024, then rose by 1.09% to -$0.14 in 2025, then fell by 1.55% to -$0.15 in 2026.
  • Business Quant data shows SVRA's EPS (Basic) at -$0.15 in Q1 2026, -$0.14 in Q4 2025, and -$0.14 in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EPS (Basic) (Qtr)
1 Vertex Pharmaceuticals 128.13 Bn 120.28 Bn 2.84 Bn 4.34
2 Regeneron Pharmaceuticals 112.33 Bn 104.33 Bn 3.93 Bn 12.62
3 Argenx Se 53.24 Bn 48.05 Bn 1.41 Bn 7.59
4 Revolution Medicines 43.64 Bn 43.64 Bn - -3.06
5 BeOne Medicines 39.27 Bn 34.17 Bn 1.53 Bn 0.16
6 MindWalk Holdings 35.32 Bn 35.31 Bn 1.82 Bn 0.00
7 Royalty Pharma 33.72 Bn 35.84 Bn - 0.18
8 Alnylam Pharmaceuticals 30.58 Bn 27.27 Bn 992.69 Mn 1.23
9 Insmed 27.01 Bn 25.85 Bn 358.27 Mn -0.06
10 Savara 1.11 Bn 1.11 Bn - -0.16

Historic Data

Download Data
DateValue
Jun 30, 2026 -0.16
Mar 31, 2026 -0.15
Dec 31, 2025 -0.14
Sep 30, 2025 -0.14
Jun 30, 2025 -0.14
Mar 31, 2025 -0.12
Dec 31, 2024 -0.15
Sep 30, 2024 -0.11
Jun 30, 2024 -0.12
Mar 31, 2024 -0.11
Dec 31, 2023 -0.10
Sep 30, 2023 -0.10
Jun 30, 2023 -0.07
Mar 31, 2023 -0.07
Dec 31, 2022 -0.07
Sep 30, 2022 -0.07
Jun 30, 2022 -0.06
Mar 31, 2022 -0.05
Dec 31, 2021 -0.08
Sep 30, 2021 -0.07